These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31487270)

  • 1. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.
    Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY
    J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
    Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
    Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
    Quan J; Morrison NA; Johnson NW; Gao J
    J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Du Q; Hou Y; Wang Z; Zhang J
    Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 induces bone destruction associated with advanced oral squamous cancer via RAGE and TLR4.
    Sakamoto Y; Okui T; Yoneda T; Ryumon S; Nakamura T; Kawai H; Kunisada Y; Ibaragi S; Masui M; Ono K; Obata K; Shimo T; Sasaki A
    Biochem Biophys Res Commun; 2020 Oct; 531(3):422-430. PubMed ID: 32800556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
    Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
    J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation.
    Park J; Jung MJ; Chung WY
    Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
    Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
    J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.
    Wang Y; Wang T; Sun Y; Sun W; Wang X
    Sci Rep; 2017 Nov; 7(1):15447. PubMed ID: 29133850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual roles of cellular communication network factor 6 (CCN6) in the invasion and metastasis of oral cancer cells to bone via binding to BMP2 and RANKL.
    Hochi H; Kubota S; Takigawa M; Nishida T
    Carcinogenesis; 2023 Dec; 44(8-9):695-707. PubMed ID: 37590989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
    Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
    Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y; Zhong L; Duan D; Li T
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.